Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Samsung
Pharma
Takeda, Sun, Ono—Fierce Pharma Asia
Takeda sharpens its oncology focus. Sun Pharma buys PD-L1 developer Checkpoint Therapeutics. Ono obtained an ASO from Ionis. Plus more.
Angus Liu
Mar 14, 2025 8:45am
Takeda, WuXi, LianBio—Fierce Pharma Asia
Feb 16, 2024 8:24am
Takeda, Lonza, US legislation—Fierce Pharma Asia
Feb 2, 2024 8:15am
Roche, Eisai, Takeda and more—Fierce Pharma Asia
May 12, 2023 9:15am
For $323M, Samsung Bio purchases land to increase CDMO footprint
Jul 18, 2022 4:53pm
AstraZeneca, Takeda, Biogen, Samsung and more—Fierce Pharma Asia
Feb 4, 2022 6:26am
